Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous immunoglobulin in de-novo CIDP
2018-003592-34Phase 4Active
- Sponsor
- Aarhus University Hospital
- Start
- Mar 2019
- Countries
- 1
01
Overview
Phase 4, randomised trial of polyvalent human immunoglobulin in chronic inflammatory demyelinating polyneuropathy (CIDP) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Change in Overall Disability Sum Score. Started Mar 2019; status: active.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2018-003592-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003592-34.